Estrogen receptor 1 and Heat shock protein 90 alpha family class A member 1 (ESR1; HSP90AA1)

Estrogen receptor 1 (ESR1) and Heat shock protein 90 alpha family class A member 1 (HSP90AA1) are critical hub proteins frequently identified in network pharmacology for their extensive interactomes and central roles in disease signaling (UniProt P03372; UniProt P07900). ESR1 is a nuclear hormone receptor that functions as a ligand-activated transcription factor, mediating the effects of estrogen on cell proliferation and survival, particularly in breast and endometrial cancers (NCBI Gene ID: 2099). HSP90AA1 is a molecular chaperone that utilizes ATP hydrolysis to facilitate the folding, stabilization, and activation of numerous client proteins, including ESR1 itself (PubMed: 28273463). In the context of network pharmacology, these targets are considered hubs because they reside at the intersection of multiple oncogenic pathways, such as the PI3K/AKT and MAPK cascades (PubMed: 31235355). Therapeutic strategies involve using selective estrogen receptor modulators (SERMs) or degraders (SERDs) to inhibit ESR1, while HSP90 inhibitors aim to disrupt the stability of multiple signaling proteins simultaneously to overcome drug resistance (PubChem CID: 3016; PubChem CID: 135338738). The synergy between these targets makes them high-priority candidates for multi-target drug design and systems biology research.

Other names

Estrogen receptor alphaER-alphaNR3A1Heat shock protein 90kDa alphaHSP90AHSPCAHSPC1

Estrogen receptor 1 is targeted via competitive antagonism or proteasomal degradation to block hormonal signaling. Heat shock protein 90 alpha family class A member 1 is targeted via ATPase inhibition, which prevents the maturation and stabilization of oncogenic client proteins.